Researchers at the Francis Crick Institute and UCL have analyzed ancient DNA from Borrelia recurrentis, a type of bacteria ...

Researchers at the Francis Crick Institute and UCL have analysed ancient DNA from Borrelia recurrentis, a type of bacteria ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

Scientists say they've put together a molecular toolkit that could be used to treat a variety of brain diseases, possibly ...

Retroviral vectors that are both non-replicating and non-integrating represent a novel and attractive tool that has potential advantages for gene delivery therapy, immunotherapy, and vaccinology.

For Uditi’s parents, reading about use of CRISPR tech, or ‘genetic scissors’, to treat baby KJ, diagnosed with severe genetic disorder, reminded them of their daughter.

BOSTON, MA, USA I May 19, 2025 I Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

In addition to complementing AAV manufacturing, the company’s Plasmid DNA (pDNA) platform is now available as a standalone ...

The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.